The Latest Cardiac and Vascular News
Versatile, Wearable Continuous Monitoring Solution Provides Masimo SET® Pulse Oximetry, Proprietary Noninvasive Blood Pressure, Body Temperature, Respiration Rate, and Electrocardiography NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) announced today that Radius VSM™, a wearable, tetherless vital signs monitor, has received CE marking and is being released in limited European markets. The versatile, expandable Radius […]
Trial to study next-generation device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation MARLBOROUGH, Mass., Oct. 29, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device […]
First Patient Cases with PURE EP System Conducted at Deborah Heart and Lung Center Westport, CT, Oct. 29, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the […]
MAXREFDES104# is a wrist form factor reference design ready to collect blood oxygen, ECG, heart rate, body temperature and activity data SAN JOSE, Calif., Oct. 28, 2020 /PRNewswire/ — Save at least six months of development time using the Health Sensor Platform 3.0 (HSP 3.0) from Maxim Integrated Products, Inc. (NASDAQ: MXIM). Also […]
NICCI is Getinge’s latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure GOTHENBURG, Sweden, Oct. 26, 2020 /PRNewswire/ — Blood pressure is one of the most important variables evaluated during almost every surgical intervention, but recent […]
HANGZHOU, China, Oct. 26, 2020 /PRNewswire/ — Gmax Biopharm today announces that the first dose of GMA301 was given to the patient in its phase 1B trial to investigate the drug efficacy to treat pulmonary arterial hypertension (PAH). GMA 301 is the first antibody drug for PAH treatment. In the phase 1A trial, it […]
Results from largest genomic analysis offer pathway to preventive patient screening CHAPEL HILL, N.C., Oct. 22, 2020 /PRNewswire/ — In the largest study of its kind, researchers from the University of North Carolina at Chapel Hill (UNC) have discovered a genetic variant that can be used to predict if patients will develop hypertension from […]
– All Participants Receiving Nedosiran, Regardless of Subtype, Achieved Normalization or Near-Normalization of Urinary Oxalate, a Key PH Measure, by Day 180 in Ongoing, Open-Label Trial – – Nedosiran Was Generally Well Tolerated With No Serious Safety Concerns Identified in This Ongoing Study – LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) […]
The ICOMS device is the first destination therapy that restores natural heart pumping capacity This successful milestone is a major step towards first in human clinical trials BORDEAUX, France–(BUSINESS WIRE)–FineHeart, SA, a preclinical-stage medical device company developing an Implantable Cardiac Output Management System (ICOMS) to address the unmet need of […]
Accelerating speed to diagnosis, allowing immediate access to patient ECG data, and enabling new revenue streams for physicians credited in rapid sales growth for leading ECG analysis platform BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a healthcare innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software that delivers highly […]
